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   The fatty acid composition of bone marrow lipid was studied in 10 
normal individuals and in 90 patients with a hematologic disorders. Simu-
ltaneously, the fatty acid composition of bone marrow was studied in 
rabbits and dogs which were injected with nitromin and cortisone, and 
 others which were irradiated and subjected to periodic venesection. The 
fatty acid composition of normal human bone marrow consisted mainly of 
saturated and unsaturated fatty acid ranging from lauric acid to arachi-
donic acid. The predominant fatty acids were as follows: oleic acid 35.2 
±4.9%, palmitic acid 27.8±2.5%, linoleic acid 15.3±2.9%, palmitoleic 
acid 8.1±2.7%, stearic acid 6.3±1.4%. Lauric, myristic, linolenic, ara-
chidonic acid were also present but in smaller amounts. In the patients 
with hematologic disorders, the fatty acid. composition of bone marrow 
were variable. In the experimental study, the certain changes of fatty 
acid composition of the bone marrow were observed, but in adipose tissue 
similar variation were not observed. The conclusion drawn from this 
study were: (1) all hematologic disorders were accompanied by the abnor-
malities of fatty acid metabolism in the bone marrow, and (2) bone 
marrow, lipid had, in addition to its function as fat stores, protection of 
tissue, and filling of tissue interstices, an active role in hematopoiesis.
                  INTRODUCTION 
   The morphological and pathological studies of bone marrow in 
various hematologic disorders have been reported by many investiga-
tors. But biochemical studies, especially on fatty acid metabolism of 
the bone marrow in hematologic disorders have not been yet reported. 
The only study in this field is the report of the fatty acid composition 
of the bone marrow lipid of normal individuals by LUND et all ~. 
   The mammalian bone marrow varies considerably in its composi-
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tion. Within the same organism there are variations which are de-
pendent upon the location of the marrow, and the functional demand 
and age of the organism. This variable composition has , been noted 
frequently. 
   Although the vital role of adipose tissue as a reservoir of fat which 
can be mobilized to provide energy has long been recognized, it has 
been assumed until relatively recently that the tissue is to a large 
extent metabolically inert. But it is now clear that adipose tissue is 
not an inactive storehouse. 
   In 1962, NAGAI et ale'. reported that lipid metabolism of bone 
marrow was accelerated in cases of increased medullary hematopoiesis. 
However, it is still unknown whether the bone marrow lipid plays any 
specific role in relation with hematopoiesis. 
   In recent years, with development of gas liquid chromatography 
(GLC), the qualitative and quantitative analysis for fatty acids has 
become simplified and accurate. Among diseases with impaired lipid 
metabolism such as fatty liver, artheriosclerosis, diabetes mellitus and 
othere, there are many detail report employing GLC.314)5) Similarly, 
diseases which are due to abnormal lipid deposition, e. g. Hand-Schue-
ller-Christian disease, Gaucher's disease, and Niemann-Pick disease are 
associated with hematologic disorders. Despite the numerous reports 
in the past of total lipid contents of bone marrow such as the concen-
tration of phospholipid, cholesterol, etc. very little was known of the 
lipid metabolism of such hematologic disorders as iron deficiency ane-
mia, acute and chronic leukemia, pernicious anemia and aplastic anemia 
and others. 
   The present paper intends to discuss the relationship of lipid me-
tabolism and function of bone marrow, and to investigate the change 
in fatty acid composition in various hematologic disorders. 
1) Sampling method 
   A) Experimental study 
   Dogs and rabbits which were irradiated and were injected with 
nitromin and cortisone and were eubjected to periodic venesection. 
Following this procedure, the animals were exsanguinated under nem-
butal anesthesia and the bone marrow of the femur was removed and 
frozen at -20°C. Simultaneously, the peripheral blood and adipose 
tissue were obtained for hematological examination and for lipid ana-
lysis. 
   B) Clinical study 
   The bone marrow of patients with hematologic disorders were aspi-
rated by the routine method from the sternum or the ilium. First, 
about 0.5cc was obtained for preparation of smears, cell count, supra-
vital staining and other necessary tests. Next, 1.5 2.0cc were obtained
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for this experiment, and every effort was made to prevent hemodilution 
by peripheral blood. In addition to the study of peripheral blood and 
bone marrow smears in all of the cases the nucleated cell count was 
collated with the lipid content. 
2) Extraction of lipid 
   Lipid was extracted by the method of BLOOR6) and FOLCH et al7'. 
The extracted lipid was measured by the gravimetric method. After 
weighing it was fractionated into neutral fat and phospholipid by BARR-
ON & HANAHANN' S method . 8' 
3) Esterification of lipid 
   when fatty acids, particularly unsaturated fatty acid, are exposed 
to air, they become auto-oxidized and isomerized. The limiting factors 
that influence the rate of auto-oxidization of the fatty acid are: (1) 
unsaturated degree of fatty acids (2) existence of free acids (3) pressure 
of oxygen (4) temperature (5) existense of oxidized promotor (6) exis-
tence of oxidized preventor, etc. 
   In this experiment, auto-oxidization of fatty acids was prevented by 
the following means: 
(1) addition of oxidized preventor (hydroquinone) 
(2) cooling to --20`C (for preservation) 
(3) samples were handled as much as possible in stream of nitrogen 
    gas. 
   When GLC is used, the fatty acids are usually converted to their 
respective methylesters prior to their analysis. A number of authors 
have9'1°'l1' described procedures for preparing methylesters of fatty 
acids prior to GLC analysis. In 1961, METCALFE et all". and VORBECK 
et a113' . stated that regardless of the method employed, there was no 
difference in the GLC pattern. In this experiment STOFFEL'S method 9) 
was used for reason of simplicity and reliability. 
4) Analytical condition of gas liquid chromatography 
   In the analysis by GLC, its suitableaess is dependent upon the 
operational condition of GLC, and the choice of column used. The 
analysis of the lipid was performed by various methods in our labora-
tory, and established as show in Table 1 and 2. 
5) Qualitative and Quantitative analysis 
   For the identification of each fatty acid, reagent grade myristic 
acid (14:0), palmitic acid (16:0), palmitoleic acid (16:1), stearic acid 
(18:0), oleic acid (18:1), linoleic acid (18:2), linolenic acid (18:3),
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                        Table 1 
        Analytical Condition of Gas Liquid Chromatography 
           Apparatus HITACHI KGL-2 
           Column Diethylenglycol Succinate 25,°o Celeite 545 
           Support mesh 60-80 
            I. D. 6mm Length 3m 
            Column Temp. 200°C 
           Sample Temp. 240°C
            Detect. Temp. 200°C
           Carrier Gas He Flow Rate 26ml/min. 
           Bridge Curr. 180mA Sens 6mV-12mV 
           Detector Thermal Conductance Detector 
                        Table 2
       Analytical Condition of Gass Liquib Chromatography 
          Apparatus SHIMADZU GC-1B 
           Column Diethylenglycol Succinate 15°0 on Shimaleite 
           Support mesh 60-80 
           I. D. 4mm Length 3m 
            Column Temp. 200°C 
           Sample Temp. 280°C 
            Detect. Temp. 240-C
           Carrier Gas He Flow Rate 40mllmin. Press 4.0kg/cm2 
          H2 Flow 90m1/min. Air Flow 100ml/min. 
           Range 100V Sens 1.6-3.2 
           Detector Hydrogen Flame Ionization Detector (Type HFD-1)
arachidic acid (20:0) and arachi-
donic acid (20:4) were methy-
lesterified, respectively and the 
fatty acid retention time was 
obtained for each apparatus. 
Each retention time is shown 
in Table 3. 
   To inject fatty acid methy-
lester into GLC three different 
microsyringes (Hamilton 10pl, 
Jintan 101d, Kusano 104) were 
used. Considerable difficulties 
were met in injecting the fixed 
quantities, Thus, from the 
area of the chromatogram the 
ratio of each fatty acid was 
ascertained but the absolute qu-
antity of each fatty acid could 
not be determined. However,
       Table 3 








Myristic 14 0 6'30" 0.5555
Palmitic 16.0 11'42" 1.0000
Palmitoleic 16.1 13'06" 1.1196
Stearic 18:0 21'18" 1.8205
Oleic 18 1 23'30" 2.0085
Linoleic 18 2 27'42' 2.3675
Linolenic 18 3 34'18" 2.9316
Arachidic 20 0 38'54" 3.3322
Arachidonic 20.45.1025
0 Chain length : No. of double bonds
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if the internal standard method 
was employed then the absolute 
quantity of fatty acids could be 
determined. 
6) Reproducibility of GLC 
   In regard to reproducibility 
of the results, the samples were 
divided into three parts, and 
from each a chromatogram was 
made and compared. As shown 
in Table 4, the reproducibility 
is extremely good and the do-
viation is small. 
  EXPERIMENTAL STUDY 
Animals: 
  i) Dogs: 
      The healthy adult male 
       dogs weighing 7.0-10.0
       kg were fed on the same 
      diet for 7 weeks. 
  ii) Rabbits: 
      The healthy adult ra-
       bbits weighing 2.5-3.5
       kg weref ed on a speci-
      fic diet. (Table 5) 
1) The fatty acid composition 
   of bone marrow lipid in nor-
   mal and venesectioned ane-
   mic dogs 
   All the animals had peri-
pheral blood studies and those 
with normal blood picture were 
divided into group I (10 cases) 
and group II (10 cases). All 
animals with abnormal periphe-
ral blood were eliminated. 
Group I was used as control 
and group II had multiple perio-
        Table 4 
Reproducibility of Gas Liquid 
Chromatography
1 2 3
12:0# 3.3 3.4 3.3
14:0 5.8 5.9 5.8
16:0 20.4 20.1 20.9
16:1 6.3 6.1 6.4
18:0 7.1 7.2 7.5
18:1 27.8 28.3 27.0
18:2 15.8 15.5 16.0
18:3 8.9 9.2 8.6
20:4 4.6 4.3 4.5
# Chain length : No. of double bonds 
  Values expressed as % of total fatty 
  acidmethylesters 
         Table 5 
Composition of the Experimental 
      Diet ( /100g)
     Fats 1.9g 
     Protein 3.5 g 
     Carbonhydrate 6.9 g 
     Cellulose 2.3 g 
     Water 84.5 g
     Calcium 76 mg 
     Phosphorus 43 mg 
  Iron 1.4 mg 
  Vitamin A trace 
           Bi 0.03 mg 
           B2 0.02 mg
           C trace 
  Calorie 59ca1./100 g
12.5-13.1
24.4-24.5
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dic phlebotomies to induce anemia. 
   The hematological findings of normal dogs were as follows: ery-
throcyte (RBC) 610 x 10.4 - 710 x 104 , hemoglobin (Hb) 10.4 - 14.6 
g/dl, hematocrit (Ht) 31.0-40.5%, reticulocyte (Ret) 0.1-0.2% and 
leucocyte (WBC) 6200-10700. The serum iron ranged from 130-305 
r/dl. 
   After venesection, the hematological findings of group II were as 
follows: RBC 243 x 104 - 500 x 104 , Hb 5.3-8.8 g/dl, Ret 2.0-8.5%. 
The serum iron decreased to 51-97r/dl. In group II, reddish marrow 
was observed except for one case. 
   In group I, the fatty acid composition of the bone marrow lipid of 
dogs consisted mainly of saturated and unsaturated fatty acids ranging 
from lauric acid (12:0) to arachidonic acid (20:4). 
   The following significant changes were observed in group II: in-
crease of 18:0 and 16.0/16:1 ratio, and decrease of 16:0/18:0 ratio 
and the disappearance of 20:4. But, only in one case which had 







Fatty Acid Composition of Bone Marrow Lipid in Dog
Normal Dog Dog due to withdrawingAnemiaFatty Acid #
Mean## s. d. Range Mean## s. d. Range
Pre 14:0 0.2 0.1 0.6 1.6 0 - 0.3
14:0 2.7 1.8 3.6 2.5 2.0- 3.5
14:0-16:0 0.6 0.4- 1.0 0.4 0 - 1.6
16:0 22.8 2.721.7 2.8 16.2-25.9
16:1 8.5 1.66.2 0.9 4.6- 7.7
18:0 5.8 1.9 4.2 8.5 8.4 1.5 5.4-11.2
18:1 44.8 3.645.7 4.7
18:2 10.7 2.211.5 2.3 9.3-15.7
18:3 2.9 1.2 3.8 3.2 1.5 0 - 5.5
18:3-20:4 - 0 -- 0 - 2.1
20;4 1.1 0.6- 1.8 - 0 - 3.8
       # Chain length : No. of double bonds 
      ## Mean of the 10 cases Values 
          expressed as °o of total fatty acid methylesters 
   The fatty acid composition of the adipose tissue was almost similar 
as the bone marrow, except that the 20:4 was absent. On the other 
hand, the fatty acid composition of the adipose tissue in both groups 
did not show any variation. 
2) Fatty acid composition of bone marrow and adipose tissue of rabbits 
   under various experimental conditions
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   The hematological findings of peripheral blood in normal rabbits 
were as follows: RBC 480 x 104 - 550 x 104 , Hb 10.0-12.8 g/dl, WBC 
8500-11000, and Ret 1.7-3.0%/. All the rabbits had peripheral blood 
studies, and those with normal picture were divided into four groups. 
   The rabbits in group I were used as control and did not receive 
any treatment. Group II was injected daily with 12.5 mg cortisone 
acetate per kg of body weight and then sacrificed on the 6th, 12th and 
18th day. Group III was injected intravenously with 10 mg Nitromin 
per kg of body weight on 3 successive days, and then 6 days after the 
last injection was sacrificed. Group IV was irradiated with 445r of 
X-ray for 3 days and after the 20th day was sacrificed. 
   In group I, the average of the total lipid content was 129.5 mg/gm 
of bone marrow, in which the phospholipid content was 30.1%. The 
fatty. acid composition of the neutral fat and phospholipid fractions of 
the bone marrow are shown in Table 7 and the fatty acid composition 
of adipose tissue in Table 8. 
   The fatty acid composition of neutral fat and phospholipid frac-
tions in bone marrow of rabbits consisted mainly of saturated and 
unsaturated fatty acids ranging from lauric acid (12:0) to arachidonic 
acid (20:4). In phospholipid fraction, arachidonic acid was recognized 
in all of the cases, but in the neutral fat fraction, it was not re-
cognized in half of the cases. 

















Mean$# s d Range Mean# s. d. Range
Pre 14:0 - 0 0.6 0
14:0 1.0 0.5 0.4 2.3 1.2 0.51.6
14:0-16:0 1.1 0.7 1.5 1.3 0.6- 2.4
16:0 18.6 4.021.6 2.2 16.3-24.2
16:1 2.2 1.1 X1.0- 4.0 1.7 0.4 1.0- 1.9
16:1-18:0 1.3 0' 0.9- 3.0bx;A~'sskw ..i16'9~
18:0 8.2 1.512.6 1.9 16.8-22.7n ~
18:1 22.713 4 1.0
18:2 39.1 1.529.8 2.8
18:3 4.6 2.0 "0.5 x,6.7 wl.l 0 - 4.5
18:3-20:4 - 0 -0 - 2.9
20:4 - 05.8 0.3 4.4-10.4
# Chain length : No. of double bonds
## Mean of 10 cases
Values expressed as °o of total fatty acid metylesters
























f Dt Ft in RabbitFatty Acid 
Fatty Acid #### terd### Radiated###with Cortison with Nitromin by X-Ray
Pre 14:0 - -
14 : 01.5±0.7 1.6±0.3 1.5±0.5
0.7±0.2 0.9±0.314:0-16:0







18:3-20:4 0.3 0 0 0.5
20:4 0 0 0 0
# Chain length : No. of double bonds
# Mean of 10 cases
### Mean of 5 cases
Values expresred asof total fatty acid methylesters
Table 9
Fatty Acid Composition of Bone Marrow Lipid in Rabblit
Administered with Cortisone Acetate
Neutrl Fat Phospholipid
Fatty Acid #
#  s.d. Ranges. d. Range
Pre 14:0 - 0 0.2 0.5 0 - 1.4
14:0 1.3 0.3 0.6 1.7 0.8 0.2 0.5- 1.1
14:0-16:0 1,2 0.8 1.7 1.2 0.9- 1.7
16:0 18.7 1.824.0 1.2 21.9-25.5
16:1 1.9 0,8 1.0 3.2 1.40.9- 2.3
16:1-18:0 1.7 1.0 2.5 1.6 0.9- 2.9
18:0 7.8 0.8 6.6 9.0 16.5 1.6 14.5-18.6
18:1 21.3 0,913. - 0.3 12.6-14.5
Unknown 0 0 3.0 2.4 0 - 7.1
18:2 39.2 4,232.0 2.8 28.1-36.2
9.4 1.6 0.6 0.7- 2.518:3 6.7 1.6
18:3-20:4 - 0 1.2 0.3 0 - 0.9
20:4 00.8- 4.7
# Chain length : No. of double bonds
## Mean of 10 cases
expressed as %totalacid methylesters
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weight, the enlargement of liver, the decrease or disappearance of 
adipose tissue, the replacement of the bone marrow by yellowish mar-
row, marked increase of plasma lipid and Nefa14' . The average of 
the total lipid content was 259.7 mg/gm of bone marrow in which the 
phospholipid content was 2.0%. The fatty acid compositions of neut-
ral fat and phospholipid fractions in the bone marrow are shown in 
Table 9. The fatty acid composition of adipose tissue is shown in 
Table 8. 
   There are scarcely any difference in the fatty acid composition of 
neutral fat fraction in the bone marrow of group I and but, in the 
phospholipid fraction, noticeable differences were observed. These 
differences appeared as a prominent peak in C 18 component in the 
chromatogram, which heretofore was absent. In addition, there was 
increase of 18:2 and decrease of 20:4. While these variations in the 
bone marrow were observed, similar changes in the fatty acid compo-
sition of adipose tissue were not recognized. 
   In group III, the average of the total lipid content was 241.0 mg/ 
gm of bone marrow, in which the phospholipid content was 4.8%. 'The fatty acid composition of neutral fat and phospholipid fraction in 
the bone marrow are shown in Table 10. The marked changes were 
observed in fatty acid composition of the bone marrow. These changes 
were as follows: decrease of 16:0 and increase of 18:2 in the neutral 








s. d. Range Mean
Fatty Acidof Bne Marrow Lipid in Rabbit
Administered with Nitromin
Fatty Acid # Neutral Fat Phospholipid
Mean#### s. d. Range
Pre 14:0 0.9 trace 3.7
14:0 0.8 0.2 0.5 1.2 0.5 0.1 0.4- 0.6
14:0-16:0 0.8 0.3 0.4 1.3 0.4 0.1 0.3- 0.6
16:0 12.6 2.227.1 1.7 24.2-29.1
16:1 1.3 0.2 0.9- 1.6 0.3 0.1 0.2- 0.4
16:1-18:0 0.9 0.2 0.5 1.1 0.9 0.1 0.8- 1.0
18:0 7.0 1.4 5.6 9.9 17.1 0.4 16.6-18.2
18:1 22.6 1.012.4 0.9 10.8-14.5
18:2 47.0 3.135.1 1.0 33.9-36.5
18:3 4.8 1.0 3.5 6.4 1.3 0.1 1.0- 1.8
18:3-20:4 1.2 0.5 2.2 0.7 0.5 0.2- 1.5
20:4 0 01.0 2.0- 5.0I
~$ Chain length No. of double bonds
## Mean of 5 cases
Values expresseds °o of total fatty acid methylestersa
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the phospholipid fraction. On the other hand, these changes in the 
fatty acid composition of the adipose tissue were not recognized. 
(Table 8) 
   In group IV, the average of the total lipid content was 342.0 mg/ 
gm of bone marrow, in which the phospholipid content was 1.9%. 
The changes of the fatty acid composition of the bone marrow in 
group IV were as follows: decrease of 16:0, increase of 18:2 and 18:3 
in the neutral fat fraction and increase of 18:2 and decrease of 16:1, 
20:4 in phospholipid fraction. (Table 11) While these changes in the 
bone marrow were observed, changes in the fatty acid composition of 












Fatty Acid Composition of Bone Marrow Lipid in
Rabbit Radiated by
Neutral Fat Phospholipid
Fatty Acid # Mean$$$$ s d + Range s. d. Range
Pre 14:0 trace 0.3 trace
14:0 0.7 0.3 0.4 1.3 0.9 0.4 0.3- 1.2
14:0-16:0 0.9 0.3 0.5 1.1 0.7 0.4 0.3- 1.9
16:0 13.5 1.422.2 1.5 20.7-24.8
16:1 1.2 0.4 0.7 1.6 0.5 0.31.0
16:1-18:0 1.1 0.4 0.6- 1.7 0.8 0.5 0.3- 1.6
18:0 7.6 0.9 6.0 8.7 18.2 0.7 17.3-19.5
18:1 24.0 1.015.4 2.1 13.2-18.0
18:2 43.7 1.236.2 1.6 32.4-39.1
3.518 :3 6.6 0.9 4.9 7.0 2.3 0.9
18:3-20:4 1.0 0.2 0.7 1.3 1.0 0.3 0.5- 1.5
1.6 0 -5.020:4 0 0
$$ Chain length : No. of double bonds
# Mean of 5 cases
Values expressed as / of total fatty acid methylesters
Fig. 1. Gas Liquid Chromatogram
Fatty acid methylesters of bone marrow lipid
were(phospholipid fraction) in rabbit
injected with Nitromin
0
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Fig. 2. Gas Liquid Chromatogram 
        Fatty acid methylesters of bone marrow lipid 
        (Neutral fat fraction) in rabbit which were
        injected with Nitromin
Fig. 3. Gas Liquid Chromatogram 
        Fatty acid methylesters of adipose tissue lipid 
        in rabbit whict were injected with Nitromin
                  CLINICAL STUDY 
   The fatty acid composition of the bone marrow was investigated 
on 10 normal individuals and patients with the following disorders: 
6 iron deficiency anemia, 9 leukemia, 4 aplastic anemia, 8 malignant 
lymphoma, 1 Gaucher's disease and 42 patients with miscellaneous 
diseases. 
1) Control group 
   Ten cases which showed no evidence of hematological abnormality 
were used as controls. In all 10 cases, the M/E ratio varied from 
3.5:1 to 5:1. The fatty acid composition of bone marrow consisted 
mainly of saturated and unsaturated fatty acid ranging from lauric 
acid (12:0) to arachidonic acid (20:4). (Table 12)






(4) (5) 6) (7) 8)
Table 12
f BLipidin NormalMFatty Acid 
Fatty Acid # ( 1 )(10) Mean s. d.( (
Pre 14 : 0 1.1 0.5 0.2 0.6 0 0.1 0.6 0 0.5 0.2 0.3
14: 0 3.7 2.1 1.4 0.6 1.2 0.9 3.2 1.8 0.2 2.0 1.7
14:0-16:0 1.8 0.6 0.2 0.1 0.2 0.5 1.5 0.7 0.5 0.6 0.6
16 : 0 25.4 28.7 31.1 30.7 30.0 36.9 38.6 31.2 23.0 22.9 27.8 2.5
16: 1 7.4 0.8 6.4 9.5 10.5 7.4 8.9 10.2 8.8 10.9 8.1 2.7
18 : 0 6.9 4.5 5.0 5.6 9.2 6.3 7.1 7.4 6.5 4.5 6.3 1.4
18: 1 39.0 43.1 39.9 24.8 35.1 33.7 35.9 29.4 36.9 33.7 35.2 4.9
18 :2 11.5 13.7 14.7 17.1 13.8 18.1 11.5 15.8 17.7 18.8 15.3 2.9
18: 3 2.0 1.7 0.6 4.7 0 3.6 2.7 3.5 3.8 4.5 2.6
18:3-20:4 0 2.8 0 3.2 0 1.3 0 0 1.8 0.6 0.9
020 : 4 1.2 1.80 0 0.8 0.8 0.8
# Chain length : No. of double bonds
Values asof total fatty acid methylesters
2) Iron deficiency anemia 
   All 6 cases had microcytic hypochromic anemia in moderate degree 
and the diagnosis was confirmed by examination of serum iron, un-
saturated iron binding capacity, and the stainable iron in the bone 
marrow sections. The M/E ratio ranged between 3:1 and 0.8:1, and 
moderate to marked acceleration of erythropoiesis was noted. Mo-
reover, it was noted in the histological sections that the erythroblasts 
of the bone marrow were moderately increased and the fat content 
was moderately decreased. The significant changes were observed in 
the fatty acid composition of the bone marrow. These changes are as 
follows: increase of 18:0 and decrease of 18:1 and 18:2. (Table 13) 
One of the six cases was reexamined after complete recovery from 
anemia, and the fatty acid composition of the bone marrow was 
similar as the control, 
3) Aplastic anemia 
   In all 4 cases, the cellular elements were notably decreased and 
the fat contents of the bone marrow were markedly increased. The 
fatty acid composition of the bone marrow is shown in Table 14. 
There is very little individual difference in the various fatty acids. 
The changes of the fatty acid composition of bone marrow in aplastic 
anemia are as follows: decrease of 16:0 and 18:0, and increase of 
18:2. (Table 14) 
4) Leukemia 
   Nine cases of leukemia were studied. These cases were distributed









Fatty Acid Composition of Bone Marrow Lipid in Iron
Deficiency
Fatty Acid # (1) (2) (3) (4) (5) (6) Mean s. d.
Pre ,14:0 1.0 0.4 0.9 1.2 .0.7 0.3 0.7
3.4 2.514:0 3.7 1.1 2.7 2.3
14:0-16:0 1.0 0 0 0.2 0.8 0.9 3.6
16:0 32.4 29.2 34.5 28.6 30.9 26.2 30.6 2.0
16:1 5.4 9.2 6.6 6.9 8.2 6.2 7.1 4.1
18:0 13.1 16.8 11.2 5.2 9.7 10.7 11.1 5.7
18:1 26.4 27.0 20.3 37.2 33.3 29.3 28.9 1.8
18:2 11.0 12.8 10.1 15.3 11.4 9.9 11.7
18:3 3.1 3.5 10.5 3.1 2.2 10.2 5.5
18:3-20:4 0 0 0 0 0.6 0
2.820:4 3.9 00
# Chain length : No. of double bonds
Values expressed asof total fatty acid methylesters
Table 14
Fatty Acid Composition of Bone Marrow Lipid in
A (Hypo)-plastic Anemia
Fatty Acid ( )) Mean s. d.() () (
Pre 14:0 0.1 0 0 0
14:0 2,0 2.5 1.6 1.6 1.9
14:0-16:0 0.6 1.0 0.7 1.0
23.0 23.7 24.3 1.016:0 24.6 21.
16:1 9.2 11.4 9.9 13.2 10.9 1.6
18:0 4.1 5.5 3.2 3.1 4.1 1.0
18:1 33.4 30.2 33.0 31.1 31.9 1.3
18:2 21.8 20.7 25.6 22.0 22.5 1.8
18:3 2.8 2.7 3.0 3.3 3.0
18:3-20:40 0 0 0
20:40 0 0
Values expresed as 0 of total fatty acid methylesters
4132
as follows: 3 acute myeloid leukemia, 2 acute monocytic leukemia, 
1 acute lymphatic leukemia, 1 acute erythroleukemia, 1 leukemic lym-
phosarcoma and 1 chronic myeloid leukemia. Abovementioned 9 cases 
were divided into two groups: one group was a proliferative type in 
which the myelogram showed the marked proliferation of the nucleated
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cells more than 90% of which were blast forms; and the other showed 
inactive cellular proliferation in which the peripheral blood picture 
was nonleukemic or subleukemic and the myelogram exhibited few 
nucleated cells. The fatty acid composition of bone marrow in these 
cases are shown in Table 15. In 4 cases of the proliferative type, the 




Mean s. d. (53)46
Table 15
Fatty Acid Composition of Bone Marrow Lipid in Leukemia
Hypercellular Marrow Hypocellular Marrow
Fatty Acid # - -
(1) (2) (()) () (7) (8) (9)d.
Pre 14:0 0 0 0 0 0 1.2 0.0.7 0.5 0
14:0 2.5 2.1 0.7 2.8 2.0 4.2 2.8 5.3 3.3 2.2 3.5
14:0-16:0 0 0 0 0 0 1.3 7.0 4.0 0 1.1 2.7
16:0 32.1 39.8 35.2 31.1 32.5 3.3 18.3 28.2 24.3 23.4 26.3 24.1 3.3
16:1 10.7 10.8 10.6 9.7 10.5 0.7 5.8 10.8 7.9 10.5 10.8 9.2 2.0
18:0 12.6 5.4 10.4 7.5 9.0 2.7 12.5 5.4 14.5 6.8 7.2 9.3 3.5
18:1 26.4 27.2 33.7 28.5 28.9 2.1 35.3 38.3 28.3 32.5 31.1 35.2 3.1
18:2 12.6 9.7 9.7 13.9 11.4 1.6 14.8 9.5 15.0 15.0 19.1 14.7 3.0
18:3 3.1 5.0 0 7.3 3.8 3.7 1.5 0 4.8 2.2 2.3
18:3-20:4 0 0 0 0 0 0 0 0 0 0 0 0
20:4 0 0 0" 0 00 3.2 0
# Chain length No. of double bonds






(2 ) (3) (4) (5) (6) (7
'T'able 16
Fatty Acid Composition of Bone Marrow Lipid in
Malignant Lyphm
Fatty Acid # (1) ) (8) Mean I s. d.
Pre 14:0 0 0.7 0.7.7 0 0.8 0 0
14:0 1.5 1.3 2.1 3.4 4.5 2.4 1.8 1.7 2.3
14:0-16:0 0.8 0.7 0.9 0 0 1.1 0.4 1.3
16:0 27.4 13.0 22.9 28.9 41.5 37.9 30.4 24.5 28.9 7.2
6: 1 7.9 11.2 7.9 11.9 10.8 9.9 13.2 8.6 10.2 1.8
18:0 9,0 3.8 5.0 6.8 8.1 8.4 4.6 8.8 6.8 2.3
18:1 33.4 29.6 41.6 25.2 25.2 29.8 34.3 34.0 31.6 5.0
18:2 17.00.2 15.6 17.1 9.9 8.4 13.2 16.3 13.5 3.2
18:3 3.0 9.5 1.8 5.1 0 1.3 0 4.8 3.2
18: 3-20:4 00 0 0 0 0 0
20:4 0 4.0 1.5 0 0 0 0 0
# Chain length No. of double bonds
values expressed as io or total fatty acid methylester
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increase of 16:0 and decrease of 18:1 and 18:2. In 5 cases of the 
inactive proliferative type, there is decreas of 16:0 in the fatty acid 
composition of the bone marrow. 
   Moreover, the changes of the fatty acid composition in the prolife-
rative type of leukemia are the same as in cases of iron deficiency 
anemia in which there are proliferation of normal erythroblastic series. 
5) Malignant lymphoma 
   Eight cases of malignant lymphoma were studied. 
   These cases were distributed as follows: 2 lymphosarcoma, 4 reti-
culum cell sarcoma and 2 Hodgkin's disease. 
   The M/E ratio and the ratio of lipid content were similar to those 
of the control group. 
   The fatty acid composition of the bone marrow are shown in 
Table 16. 
                   DISCUSSION 
   The fatty acids which are the principle constituent of lipid are 
divided into tow groups; namely, one group serves as an energy sour-
ce and the other serves as structural component of the tissue, which 
in itself is necessary for the normal metabolic 'process of the cell. The 
former is mainly lauric, myristic, palmitic, palmitoleic, stearic and 
oleic acid and the latter is linoleic, linolenic, and arachidonic acid. 
   The fatty acids which have more than one double bond are of 
great importance in animal nutrition. They include the so-called 
essential fatty acids which are necessary for the animals since they 
cannot be synthesized from other fatty acids or from carbohydrates. 
However, arachidonic acid can be synthesized by the organism from 
linoleic acid in the presence of vitamin B6 . 
   In 1940 STETTEN and SCHOENHEIMER15) published their studies on the 
"mutual change" of fatty acids
, subsequently numerous similar studies 
are reported in the world literature. 
   In the bone marrow are various cells of different function and 
origin, thus the metabolism of the bone marrow is unique. 
   The proliferation of the cells in the bone marrow is usually a 
continuous process in which the lipid is utilized as the energy source, 
and a structual component of cells. 
   In the bone marrow of various pathological disorders, marked 
changes in the fatty acid composition were observed. The ratio of 
"mutual changes" of fatty acid composition are shown in Table 17 . 
There are numerous reports on the activity of cortisone in lipid meta-
bolism however, the details of this influence are not clear. In the 
rabbits which were injected with cortisone, the following changes were
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I II III IV I II III
U n saturate 0.391 0.386 0.256 0.277 0.736 0.703 0.818 0.695
16: 0/16: 1 8.454 9.842 9.692 11.250 12.705 17.142 90.333 44.400
16 : 0/18: 0 2.268 2.3971.776 1.102 1.454 1.584 1.219
18 : 0/18: 1 0.361 0.366 0.309 0.316 1.462 1.204 1.379 1.181
20:4/18:2 0 0 0 0 0.211 0.096 0.111 0.06918:0+18:1/18:2 I 07 0.943 0.840 0,9280.790 0.742 0.629 0.723 1.1
I Untreated 
II Administered with Cortisone Acetate 
III 
: Administered with Nitromin 
IV : Radiated by X-Ray
observed: increase of total lipid content in bone marrow, decrease or 
disappearance of adipose, enlargement of liver, decrease of body weight 
and increase of plasma Nefa141. These changes agree with the reports 
Of UMEHARA et al.,16) HILL et al. 17)18) and HAUSBERGER etc, 19)20) Although 
the neutral fat increased, the fattyacid composition of neutral fat in 
the bone marrow did not changed. This observation suggests that the 
fatty acid metabolism of neutral fat is not influenced by cortisone. On 
the other hand, the fatty acid composition of phospholipid fraction 
showed remarkable changes especially of essential fatty acid. These 
facts suggest that the fatty acid metabolism becomes altered by cortiso-
ne injection. And it can be demonstrated by chromatogram that the 
conversion of linoleic acid to arachidonic acid is inhibited or inactivated 
in the bone marrow. This raises the question of whether the cause of 
decreased hematopoeitic function is dependent on fat deposition in the 
bone marrow or there is an impediment of essential fatty acid metabo-
lism. 
   In the rabbits which were injected with nitromin, the increase of 
total lipid content was due to the increase of neutral fat. In the fatty 
acid compositon of neutral fat, the following changes were observed: 
decrease of 16:0, increase of 18:2, decrease of saturated/unsaturated 
ratio, 16:0/18:0 ratio and 18:0+18:1/18:2 ratio. In the phospholipid 
fraction the following changes were observed: increase of 16:0 and 
18:2 decrease of 16:1 and20:4, increase of saturated/unsaturated ratio, 
increase of 16:0/16:1 ratio and 16:0/18:0 ratio, decrease of 20:4/18:2 
ratio and 18:0+18:1/18:2 ratio. 
   In the rabbits which were irradiated, the increase of total lipid 
content was mainly in the neutral fat fraction. The changes in the 
fatty acid composition of the neutral fat were as follows: decrease of 
16:0, increase of 18:2, decrease of saturated/unsaturated ratio, increa-
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se of 16:0/16: ratio and decrease of 16:0/18:0 ratio. Whereas, in 
phospholipid fraction the following changes were observed: increase of 
18:2, decrease of 20:4, increase of 16:0/16:1 ratio, becrease of 18:0/ 
18:1 ratio and 20:4/18:2 ratio. On the other hand, these variations 
which were observed in the fatty acid composition of the bone marrow 
were not not observed in the adipose tissue. 
   Above-mentioned facts suggest that the abnormalities of fatty acid 
metabolism in bone marrow are induced by nitromin injection and 
irradiation. When rabbits were injected with nitromin or irradiated 
with X-ray, the composition of the fatty acid of the bone marrow was 
identical as that demonstrated above. 
   In 1961 LUND et al.1) reported that normal human bone marrow lipid 
was mainly composed of neutral fat and phospholipid. According to 
Lund, the neutral fat fraction consisted of 96 to 98% triglycerides and 
small amounts of free cholesterol and free fatty acids and the phos-
pholipid fraction was less than 3%. 
   However in the patients with hematologic disorders frequently the 
lipid composition of bone marrow was variable. 
   The bone marrow of the clinical cases was not fractionated into 
neutral fat and phospholipid fraction because of low sensitivity of the 
GLC apparatus (Table 1) used. 
   The fatty acid composition of normal human bone marrow consis-
ted mainly of saturated and unsaturated fatty acid ranging from lauric 
acid (12:0) to arachidonic acid (20:4). The distributions of the fatty 
acids were as follows: oleic acid 35.2::L-4.9%/, palmitic acid 27.8 F 2.5%, 
linoleic acid 15.3±2.9%, palmitoleic acid 8.1±2.7%0, stearic acid 6.3± 
1.4%, linolenic acid 2.6%, myristic acid 2.6%, myristic acid 1.7% and 
lauric acid 0.8%. Although a specific search was made for arachidonic 
acid because of its important role in human nutrition, in three of the 
ten cases no arachidonic acid was detectable. 
   As compared with the results of LUND et at.') the Americans have 
an oleic acid content as high as 46%, whereas the linoleic acid content 
is lower than those of the Japanese. These variations are probably 
due to the differences of the dietary factor of the American and the 
Japanese. 
   There are number of studies on the fatty acid composition of 
adipose tissue 21122) and serum lipid, etc.23)24)25) But there are consi-
derable differences in the findings among these reports. Comparing 
the fatty acid composition of the bone marrow lipid with above, as 
shown in Table 18, there is considerable variation in the fatty acid 
composition of adipose tissue and serum lipid. 
   The ratio of "mnutual change" of fatty acids in hematologic disord-
ers are shown in Table 19. 
   In patients witn iron deficiency anemia, the following changes 
were observed: increase of 16:0 and 18:0, decrease of 18:1 and 18:2,
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                        Table 18 
    Comparing the Fatty Acid Composition of the Bone Marrow 




Fatty Normal Human Normal Human Normal HumanBone M rroDept Ft Plasma
Acid Author Lund1> Goto21) Krut22) Tuna23) S
chrade24)  Suzuki25)
14: 0 1.7 3.2 3.2 3.4 2.3 1.5 1.0
16: 0 27.8 26.3 26.1 22.7 19.5 27.5 30.8
16 : 1 8.1 6.3 6.4 8.4 6.9 6.8 4.7
18 : 0 6.3 8.0 4.0 4.3 5.6 6.6 8.9.
18: 1 35.2 46.4 46.1 45.4 36.5 25.3 24.9
18:2 15.322.7 24.0 29.0




(1) (2) (3) (4) (5) (6)
Unsaturate 0.565 0.805 0.435 0.835 0.585 0.639
16 : 0/16: 1 3.432 4.268 2.229 3.350 2.619 2.833
16: 0/18: 0 4.413 2.729 5.927 3.833 2.531 4.250
18:0/18: 1 0.179 0.384 0.129 0.311 0.264 0.215
18:0+ 18:: 2 2.712 3.470 1.600 3.325 3.027 2.844
(1) Normal 
(2) Iron deficiency anemia 
(3) A (Hypo)-plastic anemia 
(4) Leukemia (Hypercellular type) 
(5) Leukemia (Hypocellular type) 
(6) Malignant lymphoma
   increase of saturated/unsaturated ratio, 16:0/16:1 ratio, 18:0/18:1 
ratio, and 18:0+18:1/18.2 ratio and decrease of 16:0/18:0 ratio. In 
patients with aplastic anemia, the, following changes were, observed: 
decrease of 16:0 and 18:0, increase of 18:2, decrease of saturated/un-
saturated ratio, 16:0/16:1 ratio, 18:0/18:1 ration and 18:0+18:1/18:2 
ratio and increase of 16:0/18:0 ratio. 
   When . iron deficiency anemia is compared with aplastic anemia, 
there is marked contrast in the hematological findings as. well as in 
the fatty acid composition of the bone marrow. (Table 19) 
   In proliferative type of leukemia, the following changes were 
observed: increase of 16:0, decrease of 18:1 and 18:2, increase of 
saturated/unsaturated ratio, 18:0/18:1 ratio and 18:0+18:1/18:2 ratio, 
and decrease of 16:0/18:0 ratio. On the other hand, in the nonpro-
lifera.tive type of leukemia, the following changes were observed: de-
crease of 16:0, decrease of 16:0/16:1 ratio and 16:0/18:0 ratio, increase
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of 18:0/18:1 ratio and 18:0+18:1/18:2 ratio. 
   Similar changes in fatty acid composition are recognized in the 
proliferative type of disorders e.g. iron deficiency anemia and leukemia. 
   The above mentioned facts suggest that all hematologic disorders 
are accompanied by the abnormalities of fatty acid metabolism in the 
bone marrow. 
                   CONCLUSION 
   In cases of hematologic disorders, various morphological and pa-
thological changes take place in the bone marrow; simultaneously 
change in the lipid metabolism of the bone marrow occur, especially in 
the biosynthesis, and decomposition of fatty acid. It is therefore con-
sidered that the bone marrow lipid has, in addition to its function as 
fat stores, protection of tissue, and filling of tissue interstices, an 
active role in hematopoiesis. 
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